Interestingly, quantification of GRP78 using QuPath showed that, despite the wide range of GRP78 H-scores among the CRC cohort, there is no difference in GRP78 H-scores between ATF6-high and ATF6-low CRC groups (Extended Data Fig. 1f,g). This evidence concerns the gene HSPA5 and colorectal carcinoma.